Skip to main content

Table 2 Association of apoptosis SNPs with prostate cancer

From: Interaction among apoptosis-associated sequence variants and joint effects on aggressive prostate cancer

Marker (Alleles

and position)

Allele

Cases N (%)

Controls N (%)

OR (95%CI)

Adj OR (95%CI)*

p value

Bonf.

p value

p trend

Permut.

p value

BIK

AA

944 (81.2)

855 (77.0)

1.00 (reference)

1.00 (reference)

0.048

1.000

0.017

1.000

rs4988366

AG

208 (17.9)

244 (22.0)

0.77 (0.63-0.95)

0.78 (0.63-0.96)

0.014

   

A41830193G

GG

12 (1.0)

14 (1.3)

0.78 (0.36-1.69)

0.79 (0.36-1.71)

0.523

   
 

AG + GG

220 (18.9)

258 (23.2)

0.78 (0.63-0.95)

0.78 (0.64-0.96)

0.014

1.000

 

0.831

BNIP3L

CC

556 (47.8)

477 (42.9)

1.00 (reference)

1.00 (reference)

0.041

1.000

0.012

0.998

rs10503786

TC

480 (41.3)

489 (44.0)

0.84 (0.71-1.00)

0.85 (0.71-1.01)

0.055

   

C26325853T

TT

103 (8.9)

122 (11.0)

0.72 (0.54-0.97)

0.73 (0.55-0.98)

0.029

   
 

TC + TT

583 (50.1)

611 (55.0)

0.82 (0.70-0.97)

0.82 (0.70-0.97)

0.020

1.000

 

0.928

CASP9

CC

320 (27.5)

348 (31.3)

1.00 (reference)

1.00 (reference)

0.075

1.000

0.023

1.000

rs1052571

TC

589 (50.6)

553 (49.8)

0.88 (0.71-1.10)

0.88 (0.71-1.09)

0.265

   

C15595919T

TT

253 (21.8)

210 (18.9)

0.76 (0.60-0.97)

0.75 (0.59-0.95)

0.026

   
 

TC + CC

842 (72.4)

763 (68.7)

0.84 (0.68-1.03)

0.83 (0.68-1.02)

0.090

1.000

 

0.998

IKBKE

CC

837 (72.0)

740 (66.6)

1.00 (reference)

1.00 (reference)

0.017

1.000

0.005

0.903

rs1539243

TC

291 (25.0)

325 (29.3)

0.79 (0.66-0.95)

0.78 (0.65-0.95)

0.014

   

C203036182T

TT

36 (3.1)

47 (4.2)

0.68 (0.43-1.06)

0.68 (0.43-1.06)

0.086

   
 

TC + TT

327 (28.1)

372 (33.5)

0.78 (0.65-0.93)

0.77 (0.64-0.92)

0.006

0.943

 

0.522

PRKCE

TT

841 (72.3)

788 (70.9)

1.00 (reference)

1.00 (reference)

0.030

1.000

0.139

0.987

rs608139

TC

304 (26.1)

288 (25.9)

0.99 (0.82-1.19)

0.98 (0.51-1.19)

0.909

   

T45789207C

CC

18 (1.5)

36 (3.2)

0.47 (0.26-0.83)

0.50 (0.28-0.88)

0.010

   
 

TC + CC

322 (27.7)

324 (29.2)

0.93 (0.78-1.12)

0.93 (0.78-1.12)

0.435

1.000

 

1.000

PRKCE

AA

556 (47.8)

482 (43.4)

1.00 (reference)

1.00 (reference)

0.045

1.000

0.013

1.000

rs935673

AG

503 (43.3)

503 (45.3)

0.87 (0.73-1.03)

0.87 (0.73-1.04)

0.107

   

A46034008G

GG

105 (9.0)

128 (11.5)

0.71 (0.53-0.95)

0.71 (0.53-0.95)

0.019

   
 

AG + GG

608 (52.3)

631 (56.8)

0.84 (0.71-0.99)

0.84 (0.71-0.99)

0.034

1.000

 

0.991

TNFRSF10B

GG

547 (47.0)

537 (48.3)

1.00 (reference)

1.00 (reference)

0.055

1.000

0.253

1.000

rs1001793

AG

448 (38.5)

458 (41.2)

0.96 (0.80-1.15)

0.96 (0.80-1.14)

0.653

   

G22956894A

AA

131 (11.3)

93 (8.4)

1.38 (1.03-1.85)

1.38 (1.03-1.85)

0.029

   
 

AG + AA

579 (49.8)

551 (49.6)

1.01 (0.86-1.19)

1.03 (0.87-1.22)

0.892

1.000

 

1.000

TNFRSF1A

AA

375 (32.2)

376 (33.8)

1.00 (reference)

1.00 (reference)

0.079

1.000

0.070

1.000

rs4149576

AG

545 (46.9)

545 (79.1)

0.78 (0.62-0.98)

0.79 (0.63-0.99)

0.034

   

A6319376G

GG

234 (20.1)

183 (16.5)

0.78 (0.61-0.99)

0.79 (0.62-1.01)

0.043

   
 

AG + GG

779 (67.0)

728 (65.5)

0.78 (0.63-0.97)

0.79 (0.63-0.98)

0.024

1.000

 

0.854

TNFRSF1A

TT

326 (28.0)

270 (24.3)

1.00 (reference)

1.00 (reference)

0.087

1.000

0.205

1.000

rs4149577

TC

571 (49.1)

591 (5302)

0.80 (0.66-0.98)

0.80 (0.66-0.98)

0.027

   

T6317783C

CC

265 (22.8)

251 (22.6)

0.87 (0.69-1.11)

0.88 (0.70-1.12)

0.266

   
 

TC + CC

836 (71.9)

842 (75.8)

0.82 (0.68-0.99)

0.83 (0.68-1.00)

0.038

1.000

 

0.141

TNFSF10

GG

630 (54.2)

668 (60.1)

1.00 (reference)

1.00 (reference)

0.026

1.000

0.014

0.977

rs4894559

AG

456 (39.2)

380 (34.2)

1.27 (1.07-1.51)

1.27 (1.06-1.51)

0.007

   

G173716071A

AA

76 (6.5)

65 (5.9)

1.24 (0.88-1.78)

1.23 (0.87-1.74)

0.227

   
 

AG + AA

532 (45.7)

445 (40.1)

1.26 (1.06-1.49)

1.26 (1.07-1.49)

0.007

1.000

 

0.594

  1. Abbreviations: Bonf., Bonferroni; Permut., Permutation; *adjusted for age and family history of PCA